TSS
ESPR

Two Sigma Securities’s Esperion Therapeutics ESPR Stock Holding History

Two Sigma Securities’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.5K Buy
+27,909
New +$88.4K 0.01% 1209
2025
Q4 		– Sell
-13,077
Closed -$34.7K – 1625
2025
Q3 		$34.7K Buy
+13,077
New +$25.3K 0.01% 1044
2023
Q4 		– Sell
-36,678
Closed -$35.9K – 3175
2023
Q3 		$35.9K Buy
+36,678
New +$53.1K ﹤0.01% 2508
2023
Q2 		– Sell
-11,792
Closed -$18.7K – 2927
2023
Q1 		$18.7K Buy
+11,792
New +$60.9K ﹤0.01% 2372
2018
Q2 		– Sell
-3,940
Closed -$285K – 2726
2018
Q1 		$285K Sell
3,940
-1,251
-24% -$91.9K ﹤0.01% 2039
2017
Q4 		$342K Buy
+5,191
New +$279K 0.01% 917
2017
Q3 		– Sell
-6,857
Closed -$317K – 992
2017
Q2 		$317K Buy
+6,857
New +$252K 0.06% 337

Other funds holding ESPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return